Skip to main content Accessibility help
×
Home

Inositol for the prevention of neural tube defects: a pilot randomised controlled trial

  • Nicholas D. E. Greene (a1), Kit-Yi Leung (a1), Victoria Gay (a1), Katie Burren (a1), Kevin Mills (a2), Lyn S. Chitty (a2) and Andrew J. Copp (a1)...
  • Please note a correction has been issued for this article.

Abstract

Although peri-conceptional folic acid (FA) supplementation can prevent a proportion of neural tube defects (NTD), there is increasing evidence that many NTD are FA non-responsive. The vitamin-like molecule inositol may offer a novel approach to preventing FA-non-responsive NTD. Inositol prevented NTD in a genetic mouse model, and was well tolerated by women in a small study of NTD recurrence. In the present study, we report the Prevention of Neural Tube Defects by Inositol (PONTI) pilot study designed to gain further experience of inositol usage in human pregnancy as a preliminary trial to a future large-scale controlled trial to evaluate efficacy of inositol in NTD prevention. Study subjects were UK women with a previous NTD pregnancy who planned to become pregnant again. Of 117 women who made contact, ninety-nine proved eligible and forty-seven agreed to be randomised (double-blind) to peri-conceptional supplementation with inositol plus FA or placebo plus FA. In total, thirty-three randomised pregnancies produced one NTD recurrence in the placebo plus FA group (n 19) and no recurrences in the inositol plus FA group (n 14). Of fifty-two women who declined randomisation, the peri-conceptional supplementation regimen and outcomes of twenty-two further pregnancies were documented. Two NTD recurred, both in women who took only FA in their next pregnancy. No adverse pregnancy events were associated with inositol supplementation. The findings of the PONTI pilot study encourage a large-scale controlled trial of inositol for NTD prevention, but indicate the need for a careful study design in view of the unwillingness of many high-risk women to be randomised.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Inositol for the prevention of neural tube defects: a pilot randomised controlled trial
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Inositol for the prevention of neural tube defects: a pilot randomised controlled trial
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Inositol for the prevention of neural tube defects: a pilot randomised controlled trial
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

* Corresponding author: A. J. Copp, email a.copp@ucl.ac.uk

References

Hide All
1. Copp, AJ, Stanier, P & Greene, ND (2013) Neural tube defects: recent advances, unsolved questions, and controversies. Lancet Neurol 12, 799810.
2. Medical Research Council Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338, 131137.
3. Osterhues, A, Ali, NS & Michels, KB (2013) The role of folic acid fortification in neural tube defects: a review. Crit Rev Food Sci Nutr 53, 11801190.
4. Tinker, SC, Hamner, HC, Qi, YP, et al. (2015) U.S. women of childbearing age who are at possible increased risk of a neural tube defect-affected pregnancy due to suboptimal red blood cell folate concentrations, National Health and Nutrition Examination Survey 2007 to 2012. Birth Defects Res A Clin Mol Teratol 103, 517526.
5. Mosley, BS, Cleves, MA, Siega-Riz, AM, et al. (2009) Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 169, 917.
6. Ahrens, K, Yazdy, MM, Mitchell, AA, et al. (2011) Folic acid intake and spina bifida in the era of dietary folic acid fortification. Epidemiology 22, 731737.
7. Cockroft, DL (1988) Changes with gestational age in the nutritional requirements of postimplantation rat embryos in culture. Teratology 38, 281290.
8. Burren, KA, Savery, D, Massa, V, et al. (2008) Gene-environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function. Hum Mol Genet 17, 36753685.
9. Greene, NDE & Copp, AJ (1997) Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med 3, 6066.
10. Cogram, P, Tesh, S, Tesh, J, et al. (2002) d-Chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects. Hum Reprod 17, 24512458.
11. Ting, SB, Wilanowski, T, Auden, A, et al. (2003) Inositol- and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3. Nat Med 9, 15131519.
12. Cogram, P, Hynes, A, Dunlevy, LPE, et al. (2004) Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol. Hum Mol Genet 13, 714.
13. Copp, AJ, Brook, FA & Roberts, HJ (1988) A cell-type-specific abnormality of cell proliferation in mutant (curly tail) mouse embryos developing spinal neural tube defects. Development 104, 285295.
14. Gustavsson, P, Greene, ND, Lad, D, et al. (2007) Increased expression of Grainyhead-like-3 rescues spina bifida in a folate-resistant mouse model. Hum Mol Genet 16, 26402646.
15. Cavalli, P, Tonni, G, Grosso, E, et al. (2011) Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy. Birth Defects Res A Clin Mol Teratol 91, 962965.
16. Seller, MJ (1981) Recurrence risks for neural tube defects in a genetic counselling clinic population. J Med Genet 18, 245248.
17. Groenen, PM, Peer, PG, Wevers, RA, et al. (2003) Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol 189, 17131719.
18. Leung, KY, Mills, K, Burren, KA, et al. (2011) Quantitative analysis of myo-inositol in urine, blood and nutritional supplements by high-performance liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879, 27592763.
19. Crider, KS, Devine, O, Hao, L, et al. (2014) Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 349, g4554.
20. Czeizel, AE & Dudás, I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327, 18321835.
21. Berry, RJ, Li, Z, Erickson, JD, et al. (1999) Prevention of neural-tube defects with folic acid in China. N Engl J Med 341, 14851490.
22. Colodny, L & Hoffman, RL (1998) Inositol – clinical applications for exogenous use. Altern Med Rev 3, 432447.
23. Levine, J, Barak, Y, Gonzalves, M, et al. (1995) Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry 152, 792794.
24. Benjamin, J, Levine, J, Fux, M, et al. (1995) Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 152, 10841086.
25. Fux, M, Levine, J, Aviv, A, et al. (1996) Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry 153, 12191221.
26. Levine, J, Aviram, A, Holan, A, et al. (1997) Inositol treatment of autism. J Neural Transm 104, 307310.
27. Apgar, BS & Churgay, CA (1993) Spontaneous abortion. Prim Care 20, 621627.
28. Czeizel, A & Metneki, J (1984) Recurrence risk after neural tube defects in a genetic counselling clinic. J Med Genet 21, 413416.
30. Focus Information Technology (2007) Genetic Counselor’s Toolbox. http://www.perinatology.com/genetics/tools.htm (accessed October 2015).
31. Firth, HV, Hurst, JA & Hall, JG (2011) Oxford Desk Reference: Clinical Genetics. Oxford: Oxford University Press; Oxford Medicine Online. http://oxfordmedicine.com/view/10.1093/med/9780192628961.001.001.0001/med-9780192628961
32. Brough, L, Rees, GA, Crawford, MA, et al. (2009) Social and ethnic differences in folic acid use preconception and during early pregnancy in the UK: effect on maternal folate status. J Hum Nutr Diet 22, 100107.
33. Peake, JN, Copp, AJ & Shawe, J (2013) Knowledge and periconceptional use of folic acid for the prevention of neural tube defects in ethnic communities in the United Kingdom: systematic review and meta-analysis. Birth Defects Res A Clin Mol Teratol 97, 444451.
34. Bupp, CP, Sarasua, SM, Dean, JH, et al. (2015) When folic acid fails: insights from 20 years of neural tube defect surveillance in South Carolina. Am J Med Genet A 167A; 22442250.
35. Mills, JL (2015) Preventing folate-related neural tube defects: problem solved, or not? Birth Defects Res A Clin Mol Teratol 103, 469470.

Keywords

Inositol for the prevention of neural tube defects: a pilot randomised controlled trial

  • Nicholas D. E. Greene (a1), Kit-Yi Leung (a1), Victoria Gay (a1), Katie Burren (a1), Kevin Mills (a2), Lyn S. Chitty (a2) and Andrew J. Copp (a1)...
  • Please note a correction has been issued for this article.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

A correction has been issued for this article: